e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Diffuse parenchymal lung disease II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of disease severity using imaging scores in pulmonary sarcoidosis
V. Botnaru, D. Calaras, O. Munteanu (Chisinau, Republic Of Moldova)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease II
Session:
Diffuse parenchymal lung disease II
Session type:
Thematic Poster Session
Number:
3641
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Botnaru, D. Calaras, O. Munteanu (Chisinau, Republic Of Moldova). Assessment of disease severity using imaging scores in pulmonary sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 3641
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Evaluating disease severity in idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017
Year: 2017
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Quantitative CT for the assessment of disease severity in interstitial lung disease
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
Questionnaire for differential diagnosis of obstructive lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 473s
Year: 2004
Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001
Assessment of survival in patients with idiopathic pulmonary fibrosis (IPF) using quantitative HRCT indexes
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Frequency and impact on prognosis of signs of pulmonary veno-occlusive disease on high resolution computed tomography in patients with scleroderma associated pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Development of the chronic obstructive pulmonary disease assessment questionnaire
Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases
Year: 2008
Comparison of biomarkers with pe severity index for severity assessment in pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Functional predictors of clinical disability in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 577s
Year: 2003
Problems hypodiagnostics of chronic obstructive pulmonary disease. Using the original questionnaire for early diagnostics of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Pulmonary disease in primary Sjögren´s syndrome: symptoms, pulmonary function tests and HRCT
Source: Eur Respir J 2004; 24: Suppl. 48, 487s
Year: 2004
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
HRCT score to control and evaluate the prognosis in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Anxiety and depression assessment in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 62s
Year: 2006
Comparision of the severity of the disease and 4 different clinical scoring systems in pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Evaluation of disease severity in bronchiectasis using impulse oscillometry
Source: ERJ Open Res, 6 (4) 00053-2020; 10.1183/23120541.00053-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept